Article
ARP Rheumatology
Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy?
Abstract
It is well established that rheumatoid arthritis is associated with an increased risk of lymphoma. The use of tumor-necrosis factor-α inhibitors as a therapy in rheumatoid arthritis has been related to higher incidence of lymphoma arising at atypical and/or unusual locations; however, recent data shows their safety. We report the case of a 79 year-old woman with rheumatoid arthritis treated with infliximab, who presented a primary breast lymphoma with cutaneous involvement.
Share
Publication:
2016-12-27
Pubmed:
Cite:
Carlos Costa, Renata Aguiar, Marília Rodrigues, Pedro Carvalho, Joana Ferreira, Mariana Santiago, Luis Rito, Jorge Silva, Cátia Duarte, JAP da Silva, Armando Malcata. Primary Breast Lymphoma with cutaneous involvement in a patient with Rheumatoid Arthritis - a complication of infliximab therapy?. ARP, nº, Apr/Jun 2017:191-195. PMID: 28375194
Copy citation
Copy citation